摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1,2,4,5-Tetrahydro-1,2,4,5-tetrazin-3,6-dion | 624-40-8

中文名称
——
中文别名
——
英文名称
1,2,4,5-Tetrahydro-1,2,4,5-tetrazin-3,6-dion
英文别名
p-urazine;diurea;[1,2,4,5]tetrazinane-3,6-dione;tetrahydro-[1,2,4,5]tetrazine-3,6-dione;Tetrahydro-[1,2,4,5]tetrazin-3,6-dion;hexahydro-1,2,4,5-tetrazine-3,6-dione;Tetrahydro-1,2,4,5-tetrazine-3,6-dione;1,2,4,5-tetrazinane-3,6-dione
1,2,4,5-Tetrahydro-1,2,4,5-tetrazin-3,6-dion化学式
CAS
624-40-8
化学式
C2H4N4O2
mdl
——
分子量
116.079
InChiKey
XMKLTEGSALONPH-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -1.3
  • 重原子数:
    8
  • 可旋转键数:
    0
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    82.3
  • 氢给体数:
    4
  • 氢受体数:
    2

安全信息

  • 海关编码:
    2933990090

SDS

SDS:af77eeb5ab81c581ad708b34a4e26787
查看

上下游信息

反应信息

点击查看最新优质反应信息

文献信息

  • Reaction of anhydrous zinc chloride with 2,3-thiophenedicarbaldehyde bis(semicarbazone) (2,3BSTCH2) and bis(thiosemicarbazone) (2,3BTSTCH2): Crystal structure of {[C6H5N2S]+[ZnCl3(C6H4N2S)]−} complex
    作者:Kusaï Alomar、Magali Allain、Pascal Richomme、Gilles Bouet
    DOI:10.1515/chempap-2015-0171
    日期:2015.1.1
    the formation of compound [C6H5N2S]+[ZnCl3(C6H4N2S)]−}, where C6H4N2S is thieno[2,3-d]pyridazine, via an elimination-cyclisation reaction of the semi-carbazone or the thiosemicarbazone moiety. Crystal structures of thieno[2,3-d]pyridazine and [C6H5N2S]+[ZnCl3(C6H4N2S)]−} are described.
    无水氯化锌与2,3-噻吩二甲醛双(半碳zone)或2,3-双(硫半碳carb)的反应导致形成化合物[C 6 H 5 N 2 S] + [ZnCl 3(C 6 H 4 N 2 S)] - },其中C 6 H 4 N 2 S是噻吩并[2,3- d ]哒嗪,通过半卡巴zone或硫代半卡巴moiety部分的消除环化反应。噻吩并[2,3- d ]哒嗪和[C 6 H 5 N 2 S] +的晶体结构描述[ZnCl 3(C 6 H 4 N 2 S)] - }。
  • SMALL MOLECULE INHIBITORS OF NADS, NAMNAT, AND NMNAT
    申请人:Brouillette Wayne J.
    公开号:US20110275635A1
    公开(公告)日:2011-11-10
    Small molecule inhibitors of bacterial nicotinamide adenine dinucleotide synthetase (NADs), bacterial nicotinic acid mononucleotide adenylyltransferase (NaMNAT), and human nicotinamide mononucleotide adenylyltransferase (NMNAT) are provided, as well as methods of making and using the inhibitors.
    提供了细菌烟酰胺腺嘌呤二核苷酸合成酶(NADs)、细菌烟酸单核苷酸腺苷酰转移酶(NaMNAT)和人类烟酰胺单核苷酸腺苷酰转移酶(NMNAT)的小分子抑制剂,以及制备和使用这些抑制剂的方法。
  • Gmelin Handbuch der Anorganischen Chemie, Gmelin Handbook: N: MVol.2, 1.6, page 307 - 310
    作者:
    DOI:——
    日期:——
  • NEUGEBAUER, F. A.;FISCHER, H., LIEBIGS ANN. CHEM., 1982, N 3, 387-395
    作者:NEUGEBAUER, F. A.、FISCHER, H.
    DOI:——
    日期:——
  • Neugebauer, Franz Alfred; Fischer, Hans, Liebigs Annalen der Chemie, 1982, # 3, p. 387 - 395
    作者:Neugebauer, Franz Alfred、Fischer, Hans
    DOI:——
    日期:——
查看更多

同类化合物

酸四嗪 甲四嗪-氨基叔丁酯 四嗪-氨基叔丁酯 嘧啶并[4,5-e]-1,2,3,4-四嗪 二甲基-1,2,4,5-四嗪 二氯均四嗪 METHYLTETRAZINE-ACID,甲基四嗪-羧基 6-苯基-1,2,4,5-四嗪-3-胺 6-乙基-1,2,4,5-四嗪-3-胺 6-丁基氨基-3-(3,5-二甲基吡唑-1-基)四嗪 6-(3,5-二甲基吡唑-1-基)-1,2,4,5-四嗪-3-胺 3,6-二苯基-1,2,4,5-四嗪 3,6-二氨基-1,2-二氢-1,2,4,5-四嗪盐酸盐 3,6-二-4-吡啶基-1,2,4,5-四嗪 3,6-二-2-吡啶基-1,2,4,5-四嗪 3,6-二(噻吩-2-基)-1,2,4,5-四嗪 3,6-二(3-吡啶基)-1,2,4,5-四氮杂苯 3,6-二(3,5-二甲基-1H-吡唑-1-基)-1,2,4,5-四嗪 1-[6-(3,5-二甲基吡唑-1-基)-1,2,4,5-四嗪-3-基]-2-(丙-2-亚基)肼 1,2-二氢-1,2,4,5-四嗪-3,6-二酮 1,2,4,5]四嗪-3,6-二羧酸 1,2,4,5-四嗪-3-胺 1,2,4,5-四嗪-3,6-二羧酸二甲酯 1,2,4,5-四嗪 (9CI)-吡咯并[2,1-d]-1,2,3,5-四嗪 (6-肼基-1,2,4,5-四嗪-3-基)肼 3-(3,5-Dimethyl-1-pyrazolyl)-6-(2-trifluoroacetylhydrazino)-1,2,4,5-tetrazine 3-cyclohexyl-6-(3,5-dimethyl-1H-pyrazol-1-yl)[1,2,4]triazolo[4,3-b][1,2,4,5]tetrazine 3-ethyl-6-(3,5-dimethyl-1H-pyrazol-1-yl)[1,2,4]triazolo[4,3-b][1,2,4,5]tetrazine 6-pentyl-6-(3,5-dimethyl-1H-pyrazol-1-yl)[1,2,4]triazolo[4,3-b][1,2,4,5]tetrazine 3-benzyl-6-(3,5-dimethyl-1H-pyrazol-1-yl)[1,2,4]triazolo[4,3-b][1,2,4,5]tetrazine 3-methyl-6-(3,5-dimethyl-1H-pyrazol-1-yl)[1,2,4]triazolo[4,3-b][1,2,4,5]tetrazine N'-(6-(3,5-dimethyl-1H-pyrazol-1-yl)-1,2,4,5-tetrazin-3-yl)propionohydrazide 3-(2-ethylidenehydrazinyl)-6-(3,5-dimethyl-1H-pyrazol-1-yl)-1,2,4,5-tetrazine (1,2,4,5-tetrazine-3,6-diyl)dimethanol 3-amino-6-chloro-1,2,4,5-tetrazine 6-(3,5-dimethyl-1H-pyrazol-1-yl)-N-methyl-1,2,4,5-tetrazin-3-amine N-(tert-butyl)-6-(3,5-dimethyl-1H-pyrazol-1-yl)-1,2,4,5-tetrazin-3-amine 6-(3,5-dimethyl-1H-pyrazol-1-yl)-N-(prop-2-en-1-yl)-1,2,4,5-tetrazin-3-amine 3-(2-pyrimidyl)-6-(2-hydroxy)ethyl-1,2,4,5-tetrazine 3-isopropyl-6-phenyl-1,2,4,5-tetrazine 6-butylamino-3-chlorotetrazine 3,6-di(1H-pyrazol-4-yl)-1,2,4,5-tetrazine N-(1H-tetrazol-5-yl)-1,2,4,5-tetrazin-3-amine 3-(3,5-dimethylpyrazolyl)-6-[tris(hydroxylmethyl)aminomethane]-1,2,4,5-tetrazine 2-([1,2,4]triazolo[4,3-b][1,2,4,5]tetrazin-3-ylamino)-2-(hydroxymethyl)propane-1,3-diol 6-amino-1,2,4-triazolo<4,3-b><1,2,4,5>tetrazine N-phenethyl-[1,2,4]triazolo[4,3-b][1,2,4,5]tetrazin-3-amine 2,5-dioxopyrrolidin-1-yl 2-(4-(6-methyl-1,2,4,5-tetrazin-3-yl)phenyl)acetate furazano-1,2,3,4-tetrazine 1,3-dioxide